# EDF Ventures

> EDF Ventures is a VC fund in Ann Arbor backing Health Care and Biotechnology. See 49 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Ann Arbor, United States
- Total investments: 49
- Last investment: Nov 2022
- Lead investor: 8%
- Fund size: $2.5M
- Last fund: May 2014
- Last updated: Aug 2026
- Website: http://www.edfvc.com

EDF Ventures is a leading venture capital firm investing in early-stage healthcare companies.

## Contacts

5 contacts available for EDF Ventures. Shizune tracks 5 team members at EDF Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/edf-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 10 | 20% |
| Biotechnology | 8 | 16% |
| Medical Device | 7 | 14% |
| Manufacturing | 5 | 10% |
| Information Technology | 5 | 10% |

62 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 13 | 27% |
| Series A | 10 | 20% |
| Series C | 9 | 18% |
| Funding Round | 9 | 18% |
| Series D | 4 | 8% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 27 | 55% |
| France | 2 | 4% |
| United Kingdom | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Mary Lincoln Campbell | Managing Director | 3 | https://shizune.co/investors/profile/mary-lincoln-campbell |
| Jim Adox | Team Member | 20 | https://shizune.co/investors/profile/jim-adox |
| Mary Campbell | Managing Director | 0 | https://shizune.co/investors/profile/mary-campbell-5673 |
| Mike DeVries | Managing Director | 1 | https://shizune.co/investors/profile/mike-devries |
| Mike DeVries | Managing Director | 1 | https://shizune.co/investors/profile/mike-devries-2 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| BeZero Carbon | BeZero Carbon is here to build markets and environmental assets, starting with the Voluntary Carbon Market. | $50M | Series B | Nov 14, 2022 |  |
| DataBank | DataBank is a leading information management and security company, offering customized technology solutions designed to help organizations manage risk and improve their business performance. | $1.5B | Secondary Market | Aug 30, 2022 |  |
| IntelePeer | We enable companies to communicate better – driving more revenue, improving their customer experience, and making better business decisions – leveraging omni-channel Automation & Self-Service, AI, and Analytics, all delivered through a single easy-to-use cloud platform that works seamlessly with your existing business solutions. | $15M | Series D | Jun 10, 2013 |  |
| Direct Flow Medical | Direct Flow Medical is a medical device company developing a percutaneous aortic tissue valve prosthesis to provide patients requiring treatment of cardiac valve insufficiency with a safe and effective percutaneous option. Approximately 1.2 million people over the age of 65 have calcified aortic valves, yet only an estimated 150,000 are surgicallytreated each year. | $284K |  | Apr 01, 2012 |  |
| TransCorp Spine | TransCorp Spine manufactures medical devices and procedures to restore spinal function and preserve healthy tissue. Its product includes SpinePort, a MIS access system. David Lowry, Des O'Farrell, and Scott Tuinstra founded TransCorp Spine in 2008. It has its headquarters in Byron Center in Michigan. | $755K | Series A | May 12, 2011 |  |
| Sonoma Orthopedics | Sonoma Orthopedic Products designs, develops, and delivers proprietary orthopedic implants for physicians to address problematic fractures. The WaviBodyâ„¢ technology platform allows for quick, minimally invasive surgical solutions for active patients. Direct to Bone...Back To Life. | $22M | Series D | Feb 14, 2011 |  |
| Abionyx Pharma | ABIONYX Pharma is a biotech company discovering and developing innovative therapies for patients without existing or effective treatment. | $54.9M | Series C | Jul 25, 2010 |  |
| Direct Flow Medical | Direct Flow Medical is a medical device company developing a percutaneous aortic tissue valve prosthesis to provide patients requiring treatment of cardiac valve insufficiency with a safe and effective percutaneous option. Approximately 1.2 million people over the age of 65 have calcified aortic valves, yet only an estimated 150,000 are surgicallytreated each year. | $40M | Series C | Oct 05, 2009 |  |
| ValenTx | ValenTx is a development-stage medical device company that focuses on minimally-invasive methods for the treatment of morbid obesity. The company was founded in 2002 and headquartered in Maple Grove, Minnesota. | $22M | Series B | Sep 08, 2009 |  |
| Lycera | Lycera is a preclinical-stage biopharma company focused on small molecule immunomodulators for the treatment of rheumatoid arthritis, lupus erythematosus, and inflammatory bowel disease Lycera's first-in-class drugs are designed to treat immune disorders. The company's technology platforms include proprietary small molecules that modulatea target, which is central to cellular bioenergetics along with molecules that target the Th17 pathway.Drugs that emerge from the Lycera pipeline will represent first-in-class agents that have the potential for first-in-class oral efficacy without the adverse effects of current standard-of-care antiproliferative and immunosuppressive agents. | $36M | Series A | May 05, 2009 |  |

10 of 49 investments shown.

## Co-investors
- [Mission Ventures](https://shizune.co/investors/profile/mission-ventures) — VC Fund, 4 deals together
- [Spray Venture Partners](https://shizune.co/investors/profile/spray-venture-partners) — VC Fund, 4 deals together
- [VantagePoint Capital Partners](https://shizune.co/investors/profile/vantagepoint-capital-partners) — VC Fund, 4 deals together
- [Affinity Capital Management](https://shizune.co/investors/profile/affinity-capital-management) — VC Fund, 3 deals together
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund, 3 deals together
- [Dawntreader Ventures](https://shizune.co/investors/profile/dawntreader-ventures) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Chevron Technology Ventures](https://shizune.co/investors/profile/chevron-technology-ventures) — VC Fund
- [Evok Innovations](https://shizune.co/investors/profile/evok-innovations) — VC Fund
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Oil and Gas Investors in France](https://shizune.co/investors/oil-and-gas-investors-france)
- [Oil and Gas VC Funds in France](https://shizune.co/investors/oil-and-gas-vc-funds-france)
- [Oil and Gas VC Funds in Europe](https://shizune.co/investors/oil-and-gas-vc-funds-europe)

## FAQ

### What does EDF Ventures invest in?

EDF Ventures invests primarily in Health Care, Biotechnology and Medical Device startups, most often at Series B and Series A stage. Most of the 49 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact EDF Ventures?

Public channels for EDF Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at EDF Ventures?

The team at EDF Ventures includes Mary Lincoln Campbell (Managing Director), Jim Adox (Team Member) and Mary Campbell (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co